HK Stock MarketDetailed Quotes

LEADS BIOLABS-B (09887)

Watchlist
  • 74.600
  • +5.550+8.04%
15min DelayMarket Closed Aug 25 16:07 CST
14.84BMarket Cap-63.38P/E (TTM)

LEADS BIOLABS-B (09887) Cash Flow

Cumulative·All
YOY yoy
Hide blank lines yoy
Currency: CNY
2025/FY
2025/H1
2025/Q1
2024/FY
2024/H1
2024/Q1
2023/FY
2023/H1
2022/FY
Operating Cash Flow
-29.97%-154.43M
+6.58%-100.04M
+28.50%-26.37M
+38.34%-118.82M
-29.62%-107.08M
---36.87M
-341.01%-192.69M
---82.61M
---43.69M
Operating Income before the Change of Operating Capital
+17.95%-161.99M
-68.81%-146.08M
-43.84%-65.32M
+6.33%-197.43M
+20.10%-86.54M
---45.41M
-15.79%-210.78M
---108.30M
---182.04M
Profit before Tax
+34.97%-195.89M
+7.76%-166.39M
+12.94%-75.37M
+16.85%-301.22M
-2.72%-180.40M
---86.57M
-29.01%-362.25M
---175.62M
---280.79M
Interest (Income) - Adjustment
-256.81%-29.56M
----
----
---8.29M
----
----
----
----
----
Depreciation and Amortization:
-18.56%21.21M
-15.94%11.37M
-12.25%5.83M
+8.92%26.04M
+19.62%13.52M
--6.65M
+37.31%23.91M
--11.31M
--17.41M
-Amortization of Intangible Assets
--435.00K
--99.00K
--55.00K
----
----
----
----
----
----
Revaluation Surplus:
-101.34%-541.00K
-101.14%-470.00K
-101.19%-368.00K
-63.67%40.37M
-21.34%41.08M
--30.91M
+36.97%111.10M
--52.23M
--81.11M
-Other Fair Value Changes
-101.34%-541.00K
-101.14%-470.00K
-101.19%-368.00K
-63.67%40.37M
-21.34%41.08M
--30.91M
+36.97%111.10M
--52.23M
--81.11M
Asset Sale Loss (Gain):
--3.00K
--3.00K
--3.00K
----
----
----
----
----
----
-Loss (Gain) On Sale of Property, Machinery and Equipment
--3.00K
--3.00K
--3.00K
----
----
----
----
----
----
Financial Expense
+24.71%7.19M
+51.40%3.63M
+155.91%1.90M
+311.71%5.76M
+405.05%2.40M
--744.00K
+371.38%1.40M
--475.00K
--297.00K
Exchange Loss (Gain)
+1361.51%25.76M
+180.96%740.00K
+262.60%426.00K
+26.25%-2.04M
+84.18%-914.00K
---262.00K
+40.30%-2.77M
---5.78M
---4.64M
Special Items
-76.52%9.85M
-86.66%5.04M
-27.84%2.25M
+135.16%41.94M
+315.28%37.78M
--3.12M
+290.43%17.84M
--9.10M
--4.57M
Change of Operating Capital
-220.58%-155.44M
+0.04%-127.58M
-49.36%-42.32M
+72.23%-48.49M
-108.35%-127.63M
---28.33M
-280.57%-174.59M
---61.26M
--96.69M
Accounts Receivable (Increase) Decrease
----
----
----
----
----
----
----
----
--181.33M
Inventory (Increase) Decrease
---58.02M
---30.81M
---18.49M
----
----
----
--2.04M
----
----
Accounts Payable Increase (Decrease)
-79.08%5.24M
+125.02%14.78M
+57.67%7.81M
+1712.94%25.05M
+178.13%6.57M
--4.95M
+88.21%-1.55M
---8.41M
---13.17M
Prepayments (Increase) Decrease
-8.43%-42.22M
+57.56%-11.51M
-247.03%-5.27M
-321.14%-38.94M
-191.11%-27.11M
--3.59M
+163.38%17.61M
--29.76M
---27.78M
Special Items for Working Capital Changes
+11.59%93.99M
----
----
--84.22M
----
----
----
----
----
Cash from Business Operations
-28.24%-163.00M
-62.14%-173.62M
-120.42%-81.27M
+34.04%-127.10M
-23.16%-107.08M
---36.87M
-362.58%-192.69M
---86.95M
---41.65M
Other Taxes
---15.53M
----
----
----
----
----
----
----
----
Interest Received - Operating
+190.88%24.10M
----
----
--8.29M
----
----
----
----
----
Special items of business operations
----
--73.58M
--54.91M
----
----
----
----
--4.34M
---2.04M
Net cash flow from investing
-145.36%-165.13M
+606.08%134.63M
+84.86%91.08M
-149.67%-67.30M
-37.04%19.07M
--49.27M
+150.53%135.49M
--30.29M
--54.08M
Sale of Fixed Assets
--2.00K
----
----
----
----
----
----
----
----
Purchase of Fixed Assets
-176.47%-8.23M
+5.38%-1.78M
+70.37%-384.00K
+74.63%-2.98M
+49.37%-1.88M
---1.30M
+59.73%-11.73M
---3.71M
---29.12M
Purchase of Intangible Assets
---2.19M
---219.00K
----
----
----
----
----
----
----
Cash Received from Disposal of Investments
+359.17%166.72M
+552.27%136.63M
+80.88%91.46M
-143.69%-64.33M
-38.39%20.95M
--50.56M
+76.93%147.22M
--34.00M
--83.21M
Decrease in Deposits (Increase)
---321.43M
----
----
----
----
----
----
----
----
Financing Cash Flow
+285.17%1.19B
-87.08%14.63M
-113.16%-5.67M
+524.38%309.02M
+421.77%113.29M
--43.10M
+1690.87%49.49M
--21.71M
---3.11M
New Borrowing
+24.01%341.00M
+30.19%220.00M
+36.92%89.00M
+350.79%274.98M
+463.27%168.98M
--65.00M
--61.00M
--30.00M
----
Refund
-314.92%-336.00M
-290.16%-195.00M
-345.00%-89.00M
---80.98M
---49.98M
---20.00M
----
----
----
Issuing Shares
+938.38%1.35B
----
----
--130.00M
--505.00K
----
----
----
----
Issuance Expenses and Redemption of Securities Expenses
-2991.32%-152.46M
-220.13%-3.99M
---2.39M
---4.93M
---1.25M
----
----
----
----
Interest Paid - Financing
-26.16%-6.55M
-63.50%-3.25M
-157.78%-1.67M
+24.46%-5.19M
+67.45%-1.99M
---649.00K
---6.87M
---6.11M
----
Absorb Investment Income
----
----
----
--505.00K
----
----
----
----
----
Effects of Exchange Rate Changes
-1142.54%-22.08M
-107.99%-74.00K
-177.27%-204.00K
-21.50%2.12M
-83.99%926.00K
--264.00K
-53.18%2.70M
--5.79M
--5.76M
Ending Cash Balance
+227.79%1.22B
+54.06%421.69M
+42.23%431.38M
+50.51%372.54M
+20.21%273.72M
--303.29M
-1.98%247.52M
--227.70M
--252.53M
Net Change in Cash
+608.45%870.69M
+94.76%49.22M
+6.38%59.04M
+1695.91%122.90M
+182.56%25.27M
--55.50M
-205.78%-7.70M
---30.61M
--7.28M
Beginning Cash Balance
+50.51%372.54M
+50.51%372.54M
+50.51%372.54M
-1.98%247.52M
-1.98%247.52M
--247.52M
+5.45%252.53M
--252.53M
--239.48M
Deadline
Dec 31, 2025
Jun 30, 2025
Mar 31, 2025
Dec 31, 2024
Jun 30, 2024
Mar 31, 2024
Dec 31, 2023
Jun 30, 2023
Dec 31, 2022
Accounting Standard
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
--
--
--
--
--
--
--
--
2025/FY2025/H12025/Q12024/FY2024/H12024/Q12023/FY2023/H12022/FY

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More